ARWR Latest Headlines

Arrowhead Pharmaceuticals’ ARO-C3: Promising Early Data with Hold Rating Amid Competitive Landscape

at www.tipranks.com (Tue, 11-Mar 10:05 AM)

Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases

at www.benzinga.com (Mon, 10-Mar 2:02 PM)

Buy Rating for Arrowhead Pharmaceuticals Driven by Promising ARO-C3 Trial Results and Strategic Pipeline Advancements

at www.tipranks.com (Mon, 10-Mar 12:15 PM)

Weight-loss drug battle: Who are the latest players involved

at seekingalpha.com (Sat, 8-Mar 1:30 PM)